Plasmodium vivax and P. falciparum are the major causes of human malar
ia, except in sub-Saharan Africa where people lack the Duffy blood gro
up antigen, the erythrocyte receptor for P. vivax. Duffy negative huma
n erythrocytes are resistant to invasion by P. vivax and the related m
onkey malaria, P. knowlesi. Several lines of evidence in the present s
tudy indicate that the Duffy blood group antigen is the erythrocyte re
ceptor for the chemokines interleukin-8 (IL-8) and melanoma growth sti
mulatory activity (MGSA). First, IL-8 binds minimally to Duffy negativ
e erythrocytes. Second, a monoclonal antibody to the Duffy blood group
antigen blocked binding of IL-8 and other chemokines to Duffy positiv
e erythrocytes. Third, both MGSA and IL-8 blocked the binding of the p
arasite ligand and the invasion of human erythrocytes by P. knowlesi,
suggesting the possibility of receptor blockade for anti-malarial ther
apy.